The safety of stem cell treatment depends on what kind of treatment you mean, what condition is being treated, and whether it is being offered in a properly regulated setting. That matters because some stem cell treatments are established specialist procedures , while others are still experimental or are marketed without strong evidence.

Safety depends on the type of stem cell treatment

The first thing to understand is that stem cell treatment is not one single therapy. In mainstream medicine, stem cell or bone marrow transplants are established treatments for certain blood cancers and blood disorders, but they also come with significant, well-recognized risks such as infection, bleeding, graft-versus-host disease, and side effects from chemotherapy or radiotherapy given before the transplant. The NHS makes clear that these treatments are specialist procedures with serious potential complications and close medical supervision.

That is very different from the way stem cell treatment is often discussed in orthopedics or regenerative medicine. In those settings, the goal is usually to try to support tissue repair or improve symptoms in joints, tendons, ligaments, or cartilage. The science is promising in places, but many of these uses are still being studied rather than treated as fully established routine care.

Some treatments are regulated and some are not well proven

A useful rule is this: a properly regulated, evidence-based stem cell treatment offered in a specialist setting is very different from a treatment sold with broad claims and little supporting evidence. In the UK, cell and tissue-based advanced therapies fall under formal regulatory frameworks involving bodies such as the MHRA and HTA, which are there to help ensure quality and safety.

At the same time, regulators and expert groups warn that many advertised stem cell interventions remain unproven. EuroStemCell says stem cell treatments should only be performed in specialized centers authorized by national health authorities and warns that some advertised products have not gone through rigorous regulatory approval. The FDA also says many regenerative medicine products are illegally marketed, have not been shown to be safe or effective, and in some cases may pose significant safety risks.

That warning is not theoretical. The FDA continues to receive reports of serious adverse events, including deaths, involving unapproved products from human cells or tissues, and it says such products may not have had their quality, safety, purity, or potency properly verified.

Orthopedic uses need extra caution

This is especially important in musculoskeletal care. If someone is considering stem cell treatment for osteoarthritis or another orthopedic problem, the current evidence should be described honestly. NHS England's decision aids for knee and hip osteoarthritis state that there is no good evidence that stem cell therapy helps with osteoarthritis pain. NICE also says intra-articular stem cell injections for osteoarthritis are experimental and should not be used outside research, recommending further research instead.

That does not mean the field is meaningless . It means safety and effectiveness are not yet established enough to treat these uses like standard routine care. Research groups in the UK, including work linked to the Royal National Orthopedic Hospital, are still running studies specifically to establish safety and guide larger trials.

So, are stem cell treatments safe?

The fairest answer is that some forms of stem cell treatment can be safe when they are evidence-based, properly regulated, and delivered in specialist centers with the right safeguards. But not every treatment marketed under the stem cell banner meets that standard. Safety depends on the exact product, the condition being treated, the strength of the evidence, and the quality of the clinic or hospital offering it.

For patients, the safest approach is to ask clear questions before going ahead. Is this treatment approved or still experimental? What evidence supports it for my condition? What are the known risks and side effects? Who regulates it, and who is providing it? Those questions matter because “regenerative” does not automatically mean safe, and “stem cell” does not automatically mean proven.

If you are exploring stem cell treatment for a joint, tendon, or other musculoskeletal problem, the best next step is a proper clinical assessment and a careful discussion of the evidence, the risks, and the alternatives. Read more from Regenesis or speak to a qualified clinician about whether regenerative treatment is appropriate for your specific condition and goals .